Skyec Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.00 Cr
- Satisfied Charges ₹ 27.35 Cr
- Revenue Growth 22.31%
- Profit Growth 30.70%
- Ebitda 33.07%
- Net Worth 51.42%
- Total Assets 43.82%
About Skyec Drugs And Pharmaceuticals
Skyec Drugs And Pharmaceuticals Private Limited (SDAPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 July 2012 and has a history of 12 years and seven months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹25.00 Cr. The company has closed loans amounting to ₹27.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ethirajan and Cristwin Chellathangam serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100TN2012PTC086704
-
Company No.
086704
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jul 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Skyec Drugs And Pharmaceuticals Private Limited offer?
Skyec Drugs And Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmaceutical Syrup, Pet Accessories, Pet Products, Veterinary Medicines, Poultry Medicines, Dog Medicines, Pet Care, Pet Health Care, Pet Grooming.
Who are the key members and board of directors at Skyec Drugs And Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cristwin Chellathangam
|
Director | 11-Jul-2012 | Current |
|
Ethirajan
|
Director | 11-Jul-2012 | Current |
Financial Performance of Skyec Drugs And Pharmaceuticals.
Skyec Drugs And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.31% increase. The company also saw a substantial improvement in profitability, with a 30.7% increase in profit. The company's net worth Soared by an impressive increase of 51.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skyec Drugs And Pharmaceuticals?
In 2023, Skyec Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹25.00 Cr
₹27.35 Cr
Charges Breakdown by Lending Institutions
- Others : 25.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Oct 2023 | Others | ₹25.00 Cr | Open |
| 21 Dec 2022 | Others | ₹24.00 Cr | Satisfied |
| 19 Aug 2021 | Axis Bank Limited | ₹1.00 Cr | Satisfied |
| 13 Jul 2021 | Axis Bank Limited | ₹2.00 Cr | Satisfied |
| 24 Aug 2017 | Indian Bank | ₹3.50 M | Satisfied |
How Many Employees Work at Skyec Drugs And Pharmaceuticals?
Skyec Drugs And Pharmaceuticals has a workforce of 181 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skyec Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skyec Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.